Details of the Drug

General Information of Drug (ID: DMIPYUU)

Drug Name
PRC-4016
Indication
Disease Entry ICD 11 Status REF
Dyslipidemia 5C80-5C81 Phase 2 [1]
Arteriosclerosis BD40 Investigative [2]
Structure
3D MOL is unavailable 2D MOL
Chemical Identifiers
Formula
C24H38O3
Canonical SMILES
CCC=CCC=CCC=CCC=CCC=CCCCCOC(CC)C(=O)O
InChI
InChI=1S/C24H38O3/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-27-23(4-2)24(25)26/h5-6,8-9,11-12,14-15,17-18,23H,3-4,7,10,13,16,19-22H2,1-2H3,(H,25,26)/b6-5-,9-8-,12-11-,15-14-,18-17-
InChIKey
VOGXDRFFBBLZBT-AAQCHOMXSA-N
Cross-matching ID
PubChem CID
78210211
CAS Number
1253909-57-7
UNII
562599X5JL
DrugBank ID
DB12990
TTD ID
D03WAT
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 ClinicalTrials.gov (NCT01972178) Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia. U.S. National Institutes of Health.
2 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.